No. 92-1, January 2025

Full content is available for members only

Index

Litigation Against FDA in a Post-Chevron World.
Managing Corporate Discovery to Prevent a Reptile Attack.
Obtaining Evidence in Canada for United States Civil Actions: What American Counsel and Clients Need to Know.
The Fallout of SFFA v. Harvard: Implications for Diversity, Equity, and Inclusion in Law Firms and Corporations.